Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Items 801–900 of 1,033
Invasive candidiasis: A review of nonculture-based laboratory diagnostic methods
Ahmad, S., & Khan, Z. (2012) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.99482 · Cited by 67
Epidemiology and predictors of a poor outcome in elderly patients with candidemia
Guimarães, T., Nucci, M., de Mendonça, J. S., Martínez, R., Brito, L. R., Silva, N., Moretti, M. L., Salomão, R., & Colombo, A. L. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.02.005 · Cited by 79
Fungal infections in intensive care unit: Challenges in diagnosis and management
Bajwa, S., & Kulshrestha, A. (2013) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.113669 · Cited by 67
“are the most common systemic fungal infections in the intensive care unit, accounting for 9% of all such infections in the United States.[15] The most common species implicated was C.”
BackgroundInsights into Cross-Kingdom Plant Pathogenic Bacteria
Kirzinger, M. W. B., Nadarasah, G., & Stavrinides, J. (2011) · Genes · doi:10.3390/genes2040980 · Cited by 67
“Species of Salmonella, Serratia, Enterobacter, and Enterococcus are commonly considered problematic human pathogens that are frequently found in the nosocomial environment, and which cause food poisoning, general infections, and septicaemia [55-58] (Table 1).”
BackgroundInfluentialDiagnosing invasive fungal disease in critically ill patients
Hsu, J. L., Ruoss, S. J., Bower, N. D., Lin, M., Holodniy, M., & Stevens, D. A. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.581223 · Cited by 79
“Crude mortality associated with candidiasis in the ICU has been indicated to be 47% (Wisplinghoff et al., 2004).”
BackgroundCarman, A. J., Vylkova, S., & Lorenz, M. C. (2008) · Eukaryotic Cell · doi:10.1128/ec.00253-08 · Cited by 70
“Its incidence has risen sharply in recent years, and it is now first in associated mortality among common nosocomial infections (41).”
BackgroundTal-Jasper, R., Katz, D. E., Amrami, N., Ravid, D., Avivi, D., Zaidenstein, R., Lazarovitch, T., Dadon, M., Kaye, K. S., & Marchaim, D. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02656-15 · Cited by 68
Doğan, İ. S., Saraç, S., Sarı, S., Kart, D., Essiz, S. G., Vural, İ., & Dalkara, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.035 · Cited by 69
Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo
Lei, S., Zhao, H., Pang, B., Qu, R., Lian, Z., Jiang, C., Shao, D., Huang, Q., Jin, M., & Shi, J. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09805-z · Cited by 75
Ghrenassia, E., Mokart, D., Mayaux, J., Demoule, A., Rezine, I., Kerhuel, L., Calvet, L., JONG, A. D., Azoulay, É., & Darmon, M. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0539-2 · Cited by 73
Herbal Extracts with Antifungal Activity against Candida albicans: A Systematic Review
Hsu, H., Sheth, C. C., & Veses, V. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200628032116 · Cited by 94
“In addition, Candida is ranked fourth of the most common pathogens of bloodstream infections after Staphylococcus aureus and Enterococci [4].”
BackgroundEpidemiology and Prognostic Factors of Candidemia in Cancer Patients
Tang, H.-J., Liu, W.-L., Lin, H.-L., & Lai, C.-C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099103 · Cited by 66
“parapsilosis, are increasing in all populations in nosocomial infection settings [3,4,6].”
BackgroundYang, Y.-L., Wang, A.-H., Wang, C., Cheng, W.-T., Li, S., & Lo, H. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.01.011 · Cited by 73
“In the United States, yeast infection also ranks as the 4th most common cause of nosocomial bloodstream infection (Wisplinghoff et al., 2004).”
BackgroundKulhánková, K., King, J., & Salgado‐Pabón, W. (2014) · Immunologic Research · doi:10.1007/s12026-014-8538-8 · Cited by 69
“aureus is the leading cause of infective endocarditis (accounting for *40,000 cases/year) [1–4] and osteomyelitis, and the second leading cause of sepsis [1, 5, 6].”
BackgroundGonzález de Molina, F. J., León, C., Ruiz-Santana, S., Saavedra, P., & the CAVA I Study Group (2012) · Critical Care · doi:10.1186/cc11388 · Cited by 66
“are the fourth most common cause of bloodstream infection in hospitalized patients [1-4] and a leading cause of invasive fungal infection in the ICU setting [1].”
BackgroundHeil, E. L., Daniels, L. M., Long, D. M., Rodino, K. G., Weber, D. J., & Miller, M. B. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110604 · Cited by 66
“2146/ajhp110604 C andida species are the fourth most common organisms isolated from health-careassociated bloodstream infections.(1) While Candida albicans is the most common isolate, 46% of candidemias are caused by other Candida species.”
BackgroundPseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden, C. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.06.015 · Cited by 67
“[1] Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond”
BackgroundInfluentialHattemer, A., Hauser, A. R., Diaz, M. H., Scheetz, M. H., Shah, N. S., Allen, J. P., Porhomayon, J., & El-Solh, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02467-12 · Cited by 66
Sparo, M. D., Delpech, G., & Allende, N. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03073 · Cited by 78
“Although vancomycin-resistant enterococci have been clinically relevant pathogens for years, the majority of clinical data is retrospective (Wisplinghoff et al., 2004).”
BackgroundHirayama, T., Miyazaki, T., Ito, Y., Wakayama, M., Shibuya, K., Yamashita, K., Takazono, T., Saijo, T., Shimamura, S., Yamamoto, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60792-y · Cited by 69
Sepsis—A Retrospective Cohort Study of Bloodstream Infections
Santella, B., Folliero, V., Pirofalo, G. M., Serretiello, E., Zannella, C., Moccia, G., Santoro, E., Sanna, G., Motta, O., Caro, F. D., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9120851 · Cited by 69
“Previous studies detected Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and CoNS (Coagulase-negative staphylococci) strains as the most common cause of BSIs [3].”
BackgroundResultRiera, F. O., Caeiro, J. P., Angiolini, S. C., Vigezzi, C., Rodriguez, E., Icely, P. A., & Sotomayor, C. E. (2022) · Antibiotics · doi:10.3390/antibiotics11070877 · Cited by 65
“Although current guidelines recommend therapy with FLZ AFST, not all patients are tested due to a lack of supplies in regional laboratories [86].”
BackgroundMethodVancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Mave, V., Garcia-Diaz, J., Islam, T., & Hasbun, R. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp154 · Cited by 65
“Vancomycin-resistant enterococci (VRE) emerged in the late 1980s and resistance to vancomycin is now found in 60% of Enterococcus faecium isolates causing nosocomial bloodstream infections (BSIs) encountered in US healthcare institutions.(1) Two different meta-analyses have shown that vancomycin resistance is an indep…”
Action mechanisms of probiotics on Candida spp. and candidiasis prevention: an update
Ribeiro, F. D. C., Rossoni, R. D., de Barros, P. P., dos Santos, J. D., Fugisaki, L. R. D. O., Leão, M. V. P., & Junqueira, J. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14511 · Cited by 91
“Bloodstream infections with Candida species account for 8–15% of hospital-acquired sepsis in the United States (Edmond et al. 1999; Journal of Applied Microbiology 129, 175--185 © 2019 The Society for Applied Microbiology 175 Wisplinghoff et al. 2004).”
BackgroundHirano, R., Sakamoto, Y., Kudo, K., & Ohnishi, M. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s80677 · Cited by 74
Mohr, J., Friedrich, L. V., Yankelev, S., & Lamp, K. C. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.12.007 · Cited by 65
“Crude mortality rates exceed 33% (>40% in patients in ICUs) [1] and mortality in patients with vancomycin-resistant enterococcal BSIs is ca.”
BackgroundHarris, M., Mora-Montes, H. M., Gow, N. A. R., & Coote, P. J. (2009) · Microbiology · doi:10.1099/mic.0.026120-0 · Cited by 66
“Infections caused by Candida albicans have an incidence of between 1.1 and 24 cases per 100000 individuals, with an associated mortality rate of greater than 30% (Gudlaugsson et al., 2003; Wisplinghoff et al., 2004 ).”
BackgroundInfluentialNga, T. V. T., Parry, C. M., Le, T., Lan, N. P. H., Diep, T. S., Campbell, J. I., Hoàng, N. V. M., Dung, L. T., Wain, J. R., Dolecek, C., et al. (2011) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2011.10.004 · Cited by 71
Ultraviolet‐C Light for Treatment ofCandida albicansBurn Infection in Mice
Dai, T., Kharkwal, G. B., Zhao, J., Denis, T. G. S., Wu, Q., Xia, Y., Huang, L., Sharma, S. K., d’Enfert, C., & Hamblin, M. R. (2011) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2011.00886.x · Cited by 65
“fungal infection in burn patients and is now the fourth most common organism found in blood cultures in intensive care unit patients (1,6).”
BackgroundCandidemia in the Intensive Care Unit
Epelbaum, O., & Chasan, R. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.010 · Cited by 78
Kempker, R. R., Farley, M. M., Ladson, J., Satola, S. W., & Ray, S. M. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.09.021 · Cited by 66
“aureus (SA) to be the causative agent in 20% of all cases of nosocomial bacteremia and the proportion of isolates that were MRSA increased from 22% to 57% from 1995–2002 [2].”
BackgroundMalek, A., McGlynn, K. A., Taffner, S. M., Fine, L., Tesini, B. L., Wang, J., Mostafa, H. H., Petry, S., Perkins, A. S., GRAMAN, P. S., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02577-18 · Cited by 71
Routsi, C., Meletiadis, J., Charitidou, E., Gkoufa, A., Kokkoris, S., Karageorgiou, S., Giannopoulos, C., Koulenti, D., Andrikogiannopoulos, P., Perivolioti, E., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11060771 · Cited by 69
“On the other hand, candidemia’s incidence, often cited as the fourth most common bloodstream infection in the ICU [17], is increasing, particularly in ICU patients [18,19].”
BackgroundMedically Important Fungi Respond to Azole Drugs: An Update
Zavřel, M., & White, T. C. (2015) · Future Microbiology · doi:10.2217/fmb.15.47 · Cited by 69
The usefulness of whole genome sequencing in the management of Staphylococcus aureus infections
Price, J. R., Gordon, N. C., Crook, D. W., Llewelyn, M., & Paul, J. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12109 · Cited by 75
“aureus continues to cause life-threatening invasive disease worldwide [5,6].”
BackgroundThe burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004
Reik, R. A., Tenover, F. C., Klein, E. Y., & McDonald, L. C. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.04.013 · Cited by 65
“…UTIs, and WND/IAIs, it was concluded that 13.8% of BSIs, 12.8% of UTIs, and 24.9% of WND/IAIs are likely caused by enterococci (Biedenbach et al., 2004; Goldstein and Snydman, 2004; Gordon and Jones, 2003; Jones et al., 2003; Jones et al., 1997; Karlowsky et al., 2004; Wisplinghoff et al., 2004).”
BackgroundInfluentialEnterococcus faecalisinfective endocarditis: focus on clinical aspects
Dahl, A., & Bruun, N. E. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.832482 · Cited by 80
Boyle‐Vavra, S., Jones, M. B., Gourley, B. L., Holmes, M. H., Ruf, R. A. S., Balsam, A. R., Boulware, D. R., Kline, S., Jawahir, S., DeVries, A., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01593-10 · Cited by 68
“Indeed, it is the most common cause of endocarditis (25, 51), bacteremia (64), and skin and soft tissue infection in patients presenting to U.”
BackgroundMultilocus Sequence Typing for Analyses of Clonality of Candida albicans Strains in Taiwan
Chen, K.-W., Chen, Y.-C., Lo, H.-J., Odds, F. C., Wang, T.-H., Lin, C.-Y., & Li, S.-Y. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00320-06 · Cited by 64
“Invasive Candida infections continue to cause major problems of morbidity and mortality in a diverse range of debilitated and immunocompromised hosts and constitute an important public health problem (12, 13, 20, 41, 42).”
BackgroundSlyA Is a Transcriptional Regulator Involved in the Virulence of Enterococcus faecalis
Michaux, C., Sanguinetti, M., Reffuveille, F., Auffray, Y., Posteraro, B., Gilmore, M. S., Hartke, A., & Giárd, J.-C. (2011) · Infection and Immunity · doi:10.1128/iai.01132-10 · Cited by 64
“E . faecalis can transit from a commensal relationship with the host to being causative agent of invasive infection, and it is now a leading cause of nosocomial infections in the United States and Europe (36).”
Lepak, A. J., Marchillo, K., VanHecker, J., Diekema, D., & Andes, D. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01354-13 · Cited by 65
“Candida species are the fourth most common cause of nosocomial bloodstream infections in the United States (1, 2).”
BackgroundGroll, A. H., & Münster, U. (2011) · Cited by 64
Paramythiotou, E., & Routsi, C. (2016) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v5.i2.111 · Cited by 66
Regulatory mechanisms controlling morphology and pathogenesis in Candida albicans
Kadosh, D. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.04.005 · Cited by 79
“S, with an attributable mortality rate of 35–60% [1,2].”
BackgroundThom, K. A., Schweizer, M. L., Osih, R. B., McGregor, J. C., Furuno, J. P., Perencevich, E. N., & Harris, A. D. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-116 · Cited by 64
“pneumoniae bacteremia has been estimated to range from 19–50%[2,4-6].”
Fekkar, A., Dannaoui, É., Meyer, I., Imbert, S., Brossas, J., Uzunov, M., Mellon, G., Nguyen‐Quoc, S., Guiller, E., Caumes, É., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2096-9 · Cited by 76
“Because of these advantages, echinocandins are now often used as first-line treatments for candidaemia, a leading cause of bloodstream infection in hospitals which is, moreover, associated with high mortality [3, 4].”
BackgroundClerc, O. F., Prod’hom, G., Senn, L., Jaton, K., Zanetti, G. M. R., Calandra, T., & Greub, G. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12329 · Cited by 68
Responses of Candida albicans to the human antimicrobial peptide LL-37
Tsai, P.-W., Cheng, Y.-L., Hsieh, W., & Lan, C. (2014) · The Journal of Microbiology · doi:10.1007/s12275-014-3630-2 · Cited by 68
Braga-Silva, L. A., & dos Santos, A. L. S. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795843182 · Cited by 66
“cause around 10% of intensive care unit-acquired bloodstream infections and represent the third or fourth commonest bloodstream pathogen [21].”
BackgroundThe value of amphotericin B in the treatment of invasive fungal infections
Klepser, M. E. (2010) · Journal of Critical Care · doi:10.1016/j.jcrc.2010.08.005 · Cited by 77
“Candida albicans is implicated in approximately 50% of patients with candidiasis [2,3]; however, infections caused by other species, such as Candida glabrata, Candida tropicalis, Candida krusei, Candida parapsilosis, and Candida lusitaniae, are rising [4-7].”
BackgroundLi, Y., Su, T., Zhang, Y., Huang, X., Li, J., & Li, C. (2014) · Drug Delivery · doi:10.3109/10717544.2014.880756 · Cited by 67
Cutaneous manifestations of primary immunodeficiency
Smitt, J. H. S., & Kuijpers, T. W. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283623b9f · Cited by 64
Sreeramoju, P., Tolentino, J., Garcia‐Houchins, S., & Weber, S. G. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/524334 · Cited by 63
“BSI caused by gramnegative pathogens in hospitalized patients is associated with greater morbidity and higher mortality, compared with BSI caused by gram-positive bacteria.(2) Infections caused by Pseudomonas aeruginosa have been associated with particularly poor outcomes.”
MethodResultSeidl, K., Chen, L., Bayer, A. S., Hady, W. A., Kreiswirth, B. N., & Xiong, Y. Q. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05251-11 · Cited by 63
“It is the most prevalent cause of endovascular infections, including catheter sepsis and infective endocarditis (IE) (8, 46), and the second most common cause of bacteremia (8, 16).”
BackgroundSulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis
Chu, H., Zhao, L., Wang, M., Liu, Y., Gui, T., & Zhang, J. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.10.029 · Cited by 64
Ergönül, Ö., Aydın, M., Azap, A., Başaran, S., Tekin, S., Kaya, Ş., Gülsün, S., Yörük, G., Kurşun, E., Yesilkaya, A., et al. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.012 · Cited by 63
Haghi, F., Lohrasbi, V., & Zeighami, H. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4395-3 · Cited by 63
Larson, E., Cimiotti, J. P., Haas, J., Nesin, M., Allen, A., Della‐Latta, P., & Saiman, L. M. (2005) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000163669.37340.91 · Cited by 63
“Overall, the GNB isolates from both neonates and nurses’ hands had higher levels of antimicrobial resistance than the same organisms isolated from BSIs in an English children’s hospital (20) or reported in the nationwide surveillance study, Surveillance and Control of Pathogens of Epidemiologic Importance (27), which…”
BackgroundMicafungin: A New Echinocandin Antifungal
Joseph, J., Jain, R., & Danziger, L. H. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.1.53 · Cited by 69
“Candida sp are the fourth most common cause of nosocomial bloodstream infections, surpassed only by Staphylococcus aureus, Staphylococcus epidermidis, and enterococcal sp.(2) The mortality associated with candidemia is significant and is estimated to be 39% for bloodstream infections acquired both in and out of the in…”
BackgroundSwindell, K., Lattif, A. A., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/600106 · Cited by 64
“Candida species have emerged as the fourth most common cause of hospital-acquired bloodstream infections [3], and C.”
BackgroundFungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62
Shorr, A. F., Gupta, V., Sun, X., Johannes, R. S., Spalding, J., & Tabak, Y. P. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a0f95d · Cited by 62
“5) Vital signs and mental status Temperature, °F 94 22 (3) 469 (1.”
Lin, C.-Y., Chen, Y.-C., Lo, H.-J., Chen, K.-W., & Li, S.-Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00699-07 · Cited by 62
“Candida species are the most common opportunistic pathogens in debilitated or immunocompromised hosts and cause systemic candidiasis, which has high rates of morbidity and mortality (20, 21, 28, 44).”
BackgroundLuo, G., Ibrahim, A. S., French, S. W., Edwards, J. E., & Fu, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025909 · Cited by 62
“Candida species, the third most common cause of healthcareassociated bloodstream infections [1] causes approximately 60,000 cases of hematogenously disseminated candidiasis per year in the United States [2], resulting in billions of dollars of healthcare expenditures.”
BackgroundImproving the management of candidemia through antimicrobial stewardship interventions
Reed, E. E., West, J. E., Keating, E. A., Pancholi, P., Balada-Llasat, J.-M., Mangino, J. E., Bauer, K. A. A., & Goff, D. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.11.012 · Cited by 66
“Candidemia represents the fourth most common cause of nosocomial bloodstream infection in the United States and contributes significant morbidity, mortality, and hospital cost (Shorr et al., 2009; Wisplinghoff et al., 2004).”
BackgroundLi, M., Chen, Q., Shen, Y., & Liu, W. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00832.x · Cited by 70
Novel polymeric nanoparticles targeting the lipopolysaccharides of Pseudomonas aeruginosa
Long, Y., Li, Z., Bi, Q.-Q., Deng, C., Chen, Z., Bhattachayya, S., & Li, C. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.02.021 · Cited by 62
Burden of serious fungal infection in Nigeria.
(2014) · PubMed · Cited by 62
The effect of sophorolipids against microbial biofilms on medical-grade silicone
Ceresa, C., Fracchia, L., Williams, M., Banat, I. M., & Rienzo, M. A. D. D. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.12.019 · Cited by 75
Maskarinec, S. A., Park, L. P., Ruffin, F., Turner, N., Patel, N., Eichenberger, E. M., van Duin, D., Lodise, T. P., Fowler, V. G., & Thaden, J. T. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.025 · Cited by 62
“Firstly, we found comparable rates of allcause mortality to that of a prior study examining nosocomial GNB [10].”
ResultSurfactants as microbicides and contraceptive agents: a systematic in vitro study
Vieira, O. V., Hartmann, D. O., Cardoso, C. M. P., Oberdoerfer, D., Baptista, M., Santos, M. A. S., Almeida, L., Ramalho-Santos, J., & Vaz, W. L. C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002913 · Cited by 61
“Furthermore, fungal infections have recently emerged as a growing threat to human health in seriously debilitated and immunocompromised diseases, such as AIDS and cancer [17].”
BackgroundFortun, J., Meije, Y., Buitrago, M. J., Gago, S., Bernal-Martinez, L., Peman, J., Perez, M., Gomez-G Pedrosa, E., Madrid, N., Pintado, V., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku225 · Cited by 61
Lockhart, S. R., Jackson, B. R., Vallabhaneni, S., Ostrosky-Zeichner, L., Pappas, P. G., & Chiller, T. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01355-17 · Cited by 61
Formulation and evaluation of Itraconazole nanoemulsion for enhanced oral bioavailability
Thakkar, H. P., Khunt, A., Dhande, R., & Patel, A. A. (2015) · Journal of Microencapsulation · doi:10.3109/02652048.2015.1065917 · Cited by 68
“Most of the fungal infections are nosocomial, i.e. hospital borne (Wisplinghoff et al., 2004; Muskett et al., 2011).”
BackgroundAltered Micafungin Pharmacokinetics in Intensive Care Unit Patients
Lempers, V. J. C., Schouten, J. A., Hunfeld, N., Colbers, A. P. H., van Leeuwen, H. J., Burger, D. M., Verweij, P. E., Pickkers, P., & Brüggemann, R. J. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00623-15 · Cited by 69
Rigottier‐Gois, L., Alberti, A., Houël, A., Taly, J.-F., Palcy, P., Manson, J. M., Pinto, D., Matos, R. C., Carrilero, L., Montero, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029023 · Cited by 71
“They are the second most common cause of nosocomial bloodstream infections in the United States [3] and the fourth in Europe (http://www.”
BackgroundInfluentialThe Novel Candida albicans Transporter Dur31 Is a Multi-Stage Pathogenicity Factor
Mayer, F. L., Wilson, D., Jacobsen, I. D., Miramón, P., Große, K., & Hube, B. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002592 · Cited by 62
“Approximately 30–37% of patients suffering from systemic candidiasis die during the course of the infection [26,27].”
BackgroundWisplinghoff, H., Hippler, C., Bartual, S. G., Haefs, C., Stefanik, D., Higgins, P. G., & Seifert, H. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02010.x · Cited by 61
“In addition, A. baumannii blood culture isolates recovered from patients in 49 medical institutions of various sizes throughout the USA between 1995 and 1998 (SCOPE Project [24]) were analyzed.”
MethodSelf-citationVoigt, J. D., Mosier, M. C., & Darouiche, R. O. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01331-15 · Cited by 61
Factors related to outcome of bloodstream infections due to Candida parapsilosis complex
Barchiesi, F., Orsetti, E., Osimani, P., Catassi, C., Santelli, F., & Manso, E. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1704-y · Cited by 69
“hospitalized, respectively, in non-ICU and ICU wards [22].”
BackgroundEnhanced antifungal activity of fluconazole conjugated with Cu-Ag-ZnO nanocomposite
Ghosh, M., Mandal, S., Roy, A., Chakrabarty, S., Chakrabarti, G., & Pradhan, S. K. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110160 · Cited by 64
Babich, T., Naucler, P., Valik, J. K., Giske, C. G., Benito, N., Cardona, R., Rivera, A., Pulcini, C., Fattah, M. A., Haquin, J., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.11.004 · Cited by 61
Brown, D. F., Hope, R., Livermore, D. M., Brick, G., Broughton, K., George, R. C., Reynolds, R., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn354 · Cited by 69
Comparative Evolution of Morphological Regulatory Functions in Candida Species
Lackey, E., Vipulanandan, G., Childers, D. S., & Kadosh, D. (2013) · Eukaryotic Cell · doi:10.1128/ec.00164-13 · Cited by 61
Al Thaqafi, A. H. O., Farahat, F. M., Al Harbi, M. I., Al Amri, A. F. W., & Perfect, J. R. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.12.012 · Cited by 60
“Candidemia has been reported as the fourth most common type of hospital-acquired bloodstream infection (BSI) in the USA, with a higher prevalence among immune-compromised patients, where candidemia represents 11% of all BSI.(3) The incidence of candidemia in US hospitals during 2000–2005 increased from 3.”
BackgroundInfluentialBaldesi, O., Bailly, S., Ruckly, S., Lepape, A., L'Heriteau, F., Aupee, M., Boussat, S., Bervas, C., Machut, A., Berger-Carbonne, A., et al. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.03.011 · Cited by 60
Martelius, T., Jalava, J., Kärki, T., Möttönen, T., Ollgren, J. P., Lyytikäinen, O., & the Hospital Infection Surveillance team (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1109135 · Cited by 60
“infections (BSI).[1,2] Extended-spectrum -lactamases (ESBL)-”
Muthamil, S., Devi, V. A., Balasubramaniam, B., Balamurugan, K., & Pandian, S. K. (2018) · Journal of Basic Microbiology · doi:10.1002/jobm.201700529 · Cited by 66
“ranked as fourth in causing bloodstream infections [37,38].”
BackgroundBeganovic, M., Daffinee, K. E., Luther, M. K., & LaPlante, K. L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01680-20 · Cited by 61
“associated with high mortality rates (3).”
BackgroundIntact cell MALDI-TOF mass spectrometry-based approaches for the diagnosis of bloodstream infections
Scola, B. L. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.12 · Cited by 61
Bloodstream Infection in the ICU
Vallés, J., & Ferrer, R. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2009.04.005 · Cited by 69
“Data compiled through the CDC’s National Nosocomial Infections Surveillance System revealed that BSIs accounted for almost 20% of hospital-acquired infections in ICU patients, and 87% of these were associated with a central line.17 A recent nationwide surveillance study in 49 United States hospitals (SCOPE) reported t…”
BackgroundInfluentialBorst, L. B., Suyemoto, M. M., Robbins, K. M., Lyman, R. L., Martin, M. P., & Barnes, H. J. (2012) · Avian Pathology · doi:10.1080/03079457.2012.718070 · Cited by 60
“Enterococci are often viewed as beneficial commensal organisms, but they can also be opportunistic pathogens responsible for serious systemic infections and dissemination of antimicrobial resistance and virulence determinants (Richards et al., 2000; Wisplinghoff et al., 2004; Heuer et al., 2006).”
BackgroundMorphine, but Not Trauma, Sensitizes to Systemic Acinetobacter baumannii Infection
Deckman, J. M., Monroy, M. A., Daly, J. M., Meissler, J. J., Gaughan, J., Adler, M. W., & Eisenstein, T. K. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9303-6 · Cited by 60
“3% of ICU bacteremias with a mortality rate over 34% (Wisplinghoff et al. 2004).”
BackgroundInfluentialSamet, A., Śledzińska, A., Krawczyk, B., Hellmann, A. R., Nowicki, S., Kur, J., & Nowicki, B. J. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1886-9 · Cited by 65
“coli may remain viable in the hospital environment for several months [10–18].”
BackgroundNeonatal immune responses to coagulase-negative staphylococci
Strunk, T., Richmond, P., Simmer, K. N., Currie, A. J., Levy, O., & Burgner, D. P. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3281a7ec98 · Cited by 63
Borde, J., Batin, N., Rieg, S., Feik, R., Reimling, C., Kern, W. V., de With, K., Hübner, J., Ruhnke, M., & Kaier, K. (2014) · Infection · doi:10.1007/s15010-014-0633-1 · Cited by 65
“The incidence of nosocomial SAB is estimated at 20–40 cases per 100,000 inhabitants per year [3, 5].”
Blood stream infections (BSI) in severe burn patients—Early and late BSI: A 9-year study
Raz‐Pasteur, A., Hussein, K., Finkelstein, R., Ullmann, Y., & Egozi, D. (2012) · Burns · doi:10.1016/j.burns.2012.09.015 · Cited by 60
“fungal sepsis [16].”
BackgroundTragiannidis, A., Dokos, C., Lehrnbecher, T., & Groll, A. H. (2012) · Drugs · doi:10.2165/11599810-000000000-00000 · Cited by 66
Ikeh, M. A. C., Kastora, S. L., Day, A. M., Herrero-de-Dios, C. M., Tarrant, E., Waldron, K. J., Banks, A. P., Bain, J. M., Lydall, D., Veal, E. A., et al. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-05-0266 · Cited by 58
“Candida species are the fourth-most-common cause of nosocomial bloodstream infections (Wisplinghoff et al., 2004), and estimates indicate that C. albicans is responsible for ∼400,000 systemic infections per year (Brown et al., 2012).”
BackgroundFiedot, M., Maliszewska, I., Rac-Rumijowska, O., Suchorska-Woźniak, P., Lewińska, A., & Teterycz, H. (2017) · Materials · doi:10.3390/ma10040353 · Cited by 65
“albicans is the most common opportunistic fungal pathogen of humans and it is also very common as a hospital-acquired infection [36].”
Background
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.